CNR Institutional Research Information System

TURNATURI, RITA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.244
AS - Asia 1.131
EU - Europa 561
SA - Sud America 213
Continente sconosciuto - Info sul continente non disponibili 180
AF - Africa 35
OC - Oceania 2
Totale 3.366
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.175
SG - Singapore 411
IT - Italia 267
CN - Cina 257
BR - Brasile 159
VN - Vietnam 115
HK - Hong Kong 114
NL - Olanda 85
FR - Francia 61
KR - Corea 57
JP - Giappone 55
IN - India 38
GB - Regno Unito 34
CA - Canada 31
FI - Finlandia 30
DE - Germania 27
BD - Bangladesh 23
AR - Argentina 16
MX - Messico 14
EC - Ecuador 13
PL - Polonia 13
ZA - Sudafrica 13
ID - Indonesia 11
CO - Colombia 8
ES - Italia 8
IL - Israele 8
PK - Pakistan 7
VE - Venezuela 7
CR - Costa Rica 6
JM - Giamaica 6
AT - Austria 5
PH - Filippine 5
SA - Arabia Saudita 5
TR - Turchia 5
CL - Cile 4
DZ - Algeria 4
IE - Irlanda 4
EE - Estonia 3
IQ - Iraq 3
KE - Kenya 3
KZ - Kazakistan 3
MA - Marocco 3
SE - Svezia 3
AE - Emirati Arabi Uniti 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
EG - Egitto 2
GT - Guatemala 2
HN - Honduras 2
IR - Iran 2
LK - Sri Lanka 2
MT - Malta 2
PE - Perù 2
RU - Federazione Russa 2
SV - El Salvador 2
TN - Tunisia 2
UA - Ucraina 2
AL - Albania 1
AM - Armenia 1
AU - Australia 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
CG - Congo 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CM - Camerun 1
CV - Capo Verde 1
DJ - Gibuti 1
DM - Dominica 1
GE - Georgia 1
GF - Guiana Francese 1
GP - Guadalupe 1
GR - Grecia 1
HR - Croazia 1
HT - Haiti 1
HU - Ungheria 1
IS - Islanda 1
LB - Libano 1
LT - Lituania 1
LU - Lussemburgo 1
LV - Lettonia 1
MY - Malesia 1
NI - Nicaragua 1
PA - Panama 1
PG - Papua Nuova Guinea 1
PR - Porto Rico 1
PY - Paraguay 1
RO - Romania 1
TL - Timor Orientale 1
TM - Turkmenistan 1
TW - Taiwan 1
TZ - Tanzania 1
UG - Uganda 1
UY - Uruguay 1
YT - Mayotte 1
Totale 3.186
Salva come PNG Salva come JPEG
Città #
Singapore 250
San Jose 172
Santa Clara 166
Hefei 117
Hong Kong 111
Ashburn 98
Seoul 55
Lauterbourg 49
Beijing 48
Los Angeles 48
Tokyo 45
Ho Chi Minh City 31
Dallas 29
Hanoi 27
Milan 24
Boardman 21
New York 19
Rome 19
São Paulo 18
Atlanta 15
Bologna 14
Lappeenranta 14
Council Bluffs 12
Montreal 12
Mumbai 12
Naples 12
West Jordan 11
Catania 10
Cavallino 10
Helsinki 10
Chicago 9
Houston 9
Messina 9
Warsaw 9
Brasília 8
Frankfurt am Main 8
Johannesburg 8
Minamishinagawa 8
Bergamo 7
Da Nang 7
Haiphong 7
Rio de Janeiro 7
Brooklyn 6
Falkenstein 6
Munich 6
Poplar 6
Seattle 6
Turku 6
Amsterdam 5
Buffalo 5
Mexico City 5
Miami 5
Orem 5
Phoenix 5
Quito 5
Santo André 5
Caracas 4
Denver 4
Jacksonville 4
Memphis 4
New Delhi 4
Pescara 4
Philadelphia 4
San Antonio 4
San José 4
Verona 4
Vienna 4
Acerra 3
Ankara 3
Bari 3
Belém 3
Calgary 3
Charlotte 3
Chennai 3
Cheyenne 3
City of London 3
Columbus 3
Dublin 3
Guangzhou 3
Guwahati 3
Hưng Yên 3
Karachi 3
London 3
Manchester 3
Marseille 3
Medellín 3
Newark 3
Portsmouth 3
Rochester 3
Sete Lagoas 3
Staten Island 3
Stockholm 3
Taranto 3
Turin 3
Venice 3
Andradas 2
Arvin 2
Baltimore 2
Beaverton 2
Belo Horizonte 2
Totale 1.789
Salva come PNG Salva come JPEG
Nome #
Chimica Farmaceutica. Capitolo 26: Analgesici oppioidi. 331
Sensing B-amyloid with amphiphilic cyclodextrin/GO/KLVFF nanohybrid 120
Sigma-1 Receptor Inhibition Reduces Mechanical Allodynia and Modulate Neuroinflammation in Chronic Neuropathic Pain 106
KLVFF@Amphiphilic Cyclodextrin/GO Nanohybrids for β-amyloid Sensing 103
37th European Peptide Symposium-14th International Peptide Symposium 95
KLVFF Functionalized Graphene Oxide for Aβ42 Peptide Electrical Detection: A Promising Nanomaterial for the Development of Alzheimer's Disease Diagnostic Devices 92
Synthesis and Structure-Activity Relationships of (-)-cis-N-Normetazocine-Based LP1 Derivatives 91
Discovery of a novel series of potent carbonic anhydrase inhibitors with selective affinity for μ Opioid receptor for Safer and long-lasting analgesia 90
An integrable sensoristic platform for β-amyloid based on supramolecular interactions 89
CO2-derived non-isocyanate polyurethanes (NIPUs) and their potential applications 87
Nitric Oxide Photo-Donor Hybrids of Ciprofloxacin and Norfloxacin: A Shift in Activity from Antimicrobial to Anticancer Agents 82
The benzomorphan-based LP1 ligand is a suitable MOR/DOR agonist for chronic pain treatment 78
A carboxyethyl-β-cyclodextrin polymer and a defensin derived peptide complex with wound healing potential 73
From Plant to Chemistry: Sources of Active Opioid Antinociceptive Principles for Medicinal Chemistry and Drug Design 67
Intercellular communication and ion channels in neuropathic pain chronicization 64
Efficient green solvent-free CO2/epoxide cycloaddition catalyzed by a β-cyclodextrin-imidazolium-based ionic liquid 62
New Insights into the Opioid Analgesic Profile of cis-(-)-N-Normetazocine-derived Ligands 62
Multitarget opioid ligands in pain relief: New players in an old game 53
Rosemary Essential Oil-Loaded Lipid Nanoparticles: In Vivo Topical Activity from Gel Vehicles 53
Design, synthesis and biological evaluation of novel aminopropylcarboxamide derivatives as sigma ligands 52
Tetrazine–trans-cyclooctene ligation: Unveiling the chemistry and applications within the human body 50
Nitric Oxide Photo-Donor Hybrids of Ciprofloxacin and Norfloxacin: A Shift in Activity from Antimicrobial to Anticancer Agents (vol 64, pg 11597, 2021) 47
In Vitro Antioxidant Activity and In Vivo Topical Efficacy of Lipid Nanoparticles Co-Loading Idebenone and Tocopheryl Acetate 47
Mu and Delta Opioid Receptor Targeting Reduces Connexin 43-Based Heterocellular Coupling during Neuropathic Pain 47
From Plant to Chemistry: Sources of Antinociceptive Non-Opioid Active Principles for Medicinal Chemistry and Drug Design 44
(+)-and (-)-Phenazocine enantiomers: Evaluation of their dual opioid agonist/?1 antagonist properties and antinociceptive effects 44
Simultaneous targeting of MOR/DOR: A useful strategy for inflammatory pain modulation 43
Design, synthesis, in vitro evaluation, and molecular modeling studies of N- substituted benzomorphans, analogs of LP2, as novel MOR ligands 42
Synthesis, in vitro and in vivo characterization of new benzoxazole and benzothiazole-based sigma receptor ligands 42
Dual Sigma-1 receptor antagonists and hydrogen sulfide-releasing compounds for pain treatment: Design, synthesis, and pharmacological evaluation 41
(2S)-N-2-methoxy-2-phenylethyl-6,7-benzomorphan compound (2S-LP2): Discovery of a biased mu/delta opioid receptor agonist 41
Progress in the development of selective heme oxygenase-1 inhibitors and their potential therapeutic application 40
Benzomorphan skeleton, a versatile scaffold for different targets: A comprehensive review 40
Biotin-8-hydroxyquinoline conjugates and their metal complexes: Exploring the chemical properties and the antioxidant activity 40
Targeting heme Oxygenase-1 with hybrid compounds to overcome Imatinib resistance in chronic myeloid leukemia cell lines 38
Benzomorphan scaffold for opioid analgesics and pharmacological tools development: A comprehensive review 38
Idebenone: Novel Strategies to Improve Its Systemic and Local Efficacy 38
Multitarget Opioid/Non-opioid Ligands: A Potential Approach in Pain Management 37
In Vitro Evaluation of Sunscreen Safety: Effects of the Vehicle and Repeated Applications on Skin Permeation from Topical Formulations 37
A Structure- and Ligand-Based Virtual Screening of a Database of ``Small'' Marine Natural Products for the Identification of ``Blue'' Sigma-2 Receptor Ligands 37
Development of novel LP1-based analogues with enhanced delta opioid receptor profile 36
Novel N-normetazocine Derivatives with Opioid Agonist/Sigma-1 Receptor Antagonist Profile as Potential Analgesics in Inflammatory Pain 35
The Multimodal MOPr/DOPr Agonist LP2 Reduces Allodynia in Chronic Constriction Injured Rats by Rescue of TGF-β1 Signalling 35
Lp1 and lp2: Dual‐target mopr/dopr ligands as drug candidates for persistent pain relief 35
Novel N-Substituted Benzomorphan-Based Compounds: From MOR-Agonist/DOR-Antagonist to Biased/Unbiased MOR Agonists 35
Progress in the development of more effective and safer analgesics for pain management 34
Repeated activation of delta opioid receptors counteracts nerve injury-induced TNF-? up-regulation in the sciatic nerve of rats with neuropathic pain: A possible correlation with delta opioid receptors-mediated antiallodinic effect 34
Neuroprotective effects of Rosmarinus officinalis L. extract in oxygen glucose deprivation (OGD)-injured human neural-like cells 34
Antinociceptive profile of LP1, a non-peptide multitarget opioid ligand 33
Haloperidol Metabolite II Valproate Ester (S)-(−)-MRJF22: Preliminary Studies as a Potential Multifunctional Agent against Uveal Melanoma 32
Resveratrol-Loaded Lipid Nanocarriers: Correlation between In Vitro Occlusion Factor and In Vivo Skin Hydrating Effect 32
Exploiting the power of stereochemistry in drug action: 3-[(2S,6S,11S)-8-Hydroxy-6,11-dimethyl-1,4,5,6-tetrahydro-2,6-methano-3-benzazocin-3(2H)-yl]-N-phenylpropanamide as potent sigma-1 receptor antagonist 31
Antiproliferative and Antioxidant Activity of Glycoconjugates of Dithiocarbamates and Their Copper(II) and Zinc(II) Complexes 31
Solid lipid nanoparticles as carriers for the synthetic opioid lp2: Characterization and in vitro release 30
Tuning Properties for Blood-Brain Barrier Permeation: A Statistics-Based Analysis 30
Sigma receptor ligands carrying a nitric oxide donor nitrate moiety: Synthesis, in silico, and biological evaluation 28
Differential scanning calorimetry approach to investigate the transfer of the multitarget opioid analgesic LP1 to biomembrane model 28
Evaluation of N-substituent structural variations in opioid receptor profile of LP1 27
Simultaneous Activation of Mu and Delta Opioid Receptors Reduces Allodynia and Astrocytic Connexin 43 in an Animal Model of Neuropathic Pain 27
Structural Characterization, β‐Cyclodextrin Polymer Interaction, and Biological Assessment of the N‐Terminal Peptide from the RPD‐1 Big Defensin of Ruditapesphilippinarum 26
Synthesis and Structure-Activity Relationships of LP1 Derivatives: N-Methyl-N-phenylethylamino Analogues as Novel MOR Agonists 22
A supramolecular KLVFF/graphene oxide/cyclodextrin assembly for selective recognition of amyloid β 42 peptide 16
null 12
Totale 3.366
Salva come PNG Salva come JPEG
Categoria #
all - tutte 10.108
article - articoli 8.618
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 418
Totale 19.144
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202435 0 0 0 0 0 0 0 0 4 11 1 19
2024/20251.101 19 3 54 24 178 150 23 72 30 78 254 216
2025/20261.632 123 127 121 277 258 75 246 55 112 133 60 45
2026/2027598 90 258 250 0 0 0 0 0 0 0 0 0
Totale 3.366